David M. Kern, MS

Articles

April 13th 2015

Treatment Patterns, Healthcare Utilization, and Costs of Chronic Opioid Treatment for Non-Cancer Pain in the United States

David M. Kern, MS Siting Zhou, PhD Soheil Chavoshi, MS Ozgur Tunceli, PhD Mark Sostek, MD Joseph Singer, MD Robert J. LoCasale, PhD

Healthcare utilization and costs increased in the 6 months after patients started opioid therapy for chronic pain; they then decreased but never reverted to baseline levels.

March 18th 2015

Mortality, Outcomes, and Healthcare Costs in T2DM Patients at Risk for Cardiovascular Disease

David M. Kern, MS Stephanie DeVore, MSPH Jennifer Kim, PharmD Ozgur Tunceli, PhD Bingcao Wu, MS Boaz Hirshberg, MD

Targeting glucose control and managing cardiovascular (CV) risk factors may prevent future CV events, and have positive downstream impact by reducing costs to healthcare stakeholders.